Literature DB >> 11584024

T cell activity correlates with oligomeric peptide-major histocompatibility complex binding on T cell surface.

J Buslepp1, R Zhao, D Donnini, D Loftus, M Saad, E Appella, E J Collins.   

Abstract

Recognition of virally infected cells by CD8+ T cells requires differentiation between self and nonself peptide-class I major histocompatibility complexes (pMHC). Recognition of foreign pMHC by host T cells is a major factor in the rejection of transplanted organs from the same species (allotransplant) or different species (xenotransplant). AHIII12.2 is a murine T cell clone that recognizes the xenogeneic (human) class I MHC HLA-A2.1 molecule (A2) and the syngeneic murine class I MHC H-2 D(b) molecule (D(b)). Recognition of both A2 and D(b) are peptide-dependent, and the sequences of the peptides recognized have been determined. Alterations in the antigenic peptides bound to A2 cause large changes in AHIII12.2 T cell responsiveness. Crystal structures of three representative peptides (agonist, null, and antagonist) bound to A2 partially explain the changes in AHIII12.2 responsiveness. Using class I pMHC octamers, a strong correlation is seen between T cell activity and the affinity of pMHC complexes for the T cell receptor. However, contrary to previous studies, we see similar half-lives for the pMHC multimers bound to the AHIII12.2 cell surface.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11584024     DOI: 10.1074/jbc.M109231200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition.

Authors:  Alex Theodossis; Carole Guillonneau; Andrew Welland; Lauren K Ely; Craig S Clements; Nicholas A Williamson; Andrew I Webb; Jacqueline A Wilce; Roger J Mulder; Michelle A Dunstone; Peter C Doherty; James McCluskey; Anthony W Purcell; Stephen J Turner; Jamie Rossjohn
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

2.  Interaction of streptavidin-based peptide-MHC oligomers (tetramers) with cell-surface TCRs.

Authors:  Jennifer D Stone; Maxim N Artyomov; Adam S Chervin; Arup K Chakraborty; Herman N Eisen; David M Kranz
Journal:  J Immunol       Date:  2011-11-18       Impact factor: 5.422

3.  T cell cross-reactivity and conformational changes during TCR engagement.

Authors:  Jean K Lee; Guillaume Stewart-Jones; Tao Dong; Karl Harlos; Kati Di Gleria; Lucy Dorrell; Daniel C Douek; P Anton van der Merwe; E Yvonne Jones; Andrew J McMichael
Journal:  J Exp Med       Date:  2004-12-06       Impact factor: 14.307

Review 4.  Structural Prediction of Peptide-MHC Binding Modes.

Authors:  Marta A S Perez; Michel A Cuendet; Ute F Röhrig; Olivier Michielin; Vincent Zoete
Journal:  Methods Mol Biol       Date:  2022

5.  Structural allele-specific patterns adopted by epitopes in the MHC-I cleft and reconstruction of MHC:peptide complexes to cross-reactivity assessment.

Authors:  Dinler A Antunes; Gustavo F Vieira; Maurício M Rigo; Samuel P Cibulski; Marialva Sinigaglia; José A B Chies
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

6.  Accurate structure prediction of peptide-MHC complexes for identifying highly immunogenic antigens.

Authors:  Min-Sun Park; Sung Yong Park; Keith R Miller; Edward J Collins; Ha Youn Lee
Journal:  Mol Immunol       Date:  2013-05-18       Impact factor: 4.407

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.